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Abstract
Objectives: To compare the diagnostic performance of two norovirus rapid immunochromato-
graphic kits (QuickNavi-Norovirus [QN] and QuickNavi-Norovirus 2 [QN2]; Denka Seiken,
Niigata, Japan) for neonatal and infant faecal specimens.
Methods:Monthly faecal samples were collected from infants from birth to 12 months of age, and
tested for norovirus using QN and QN2. Real-time reverse transcription polymerase chain
reaction (RT–PCR) was used as the gold standard for norovirus detection. The diagnostic
performance of the kits was calculated.
Results: A total of 343 specimens from 81 infants were analysed. In all samples, the specificity of
QN and QN2 was 80% (275/343) and 99% (339/343), respectively. In infants aged <1 month, the
specificity of QN was 33% (23/70), increasing to 93% at 4 months of age. Specificity of QN2 was
94% in infants between 0 and 12 months of age.
Conclusions:QN2 offers improved performance and is more useful than QN for the diagnosis of
norovirus infection in the neonatal and infant period.
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Introduction
Norovirus is a major cause of epidemic
gastroenteritis. Rapid diagnosis of noro-
virus infection is important for the early
treatment, prevention and control of
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outbreaks, particularly in neonatal intensive
care units (NICUs). Nosocomial norovirus
outbreaks occur in NICUs,1 and can occa-
sionally result in necrotizing enterocolitis.2,3
Rapid immunochromatographic tests
for norovirus include RIDA QUICK
Norovirus (R-Biopharm AG, Darmstadt,
Germany), ImmunoCardSTAT! (Meridian
Bioscience, Inc., Ohio, United States) and
QuickNavi-Norovirus (Denka Seiken,
Niigata, Japan). These tests have sensitivity
of 92%, 92% and 82%, and specificity of
98%, 98% and 97%, respectively.4–6 We
have, however, reported a norovirus
pseudo-outbreak resulting from the pre-
sumed reduced specificity of QuickNavi-
Norovirus for neonatal faecal specimens.7 In
that case, 18 of 40 (45.0%) faecal specimens
from 10 of 14 (71.4%) neonatal patients
were false positives.
Both QuickNavi-Norovirus (QN) and
its successor QuickNavi-Norovirus 2
(QN2) include monoclonal antibodies
against norovirus genogroups (G)I and
II,6,8 while specific monoclonal antibodies
and the composition of the dilution buffer
differ between the two kits.8 QN2 has sen-
sitivity, specificity and accuracy of 92%,
98% and 94%, respectively, in adults and
children (excluding neonates).8 The effect-
iveness of QN and QN2 has not been studied
in neonatal faecal specimens.
The aim of the present study was to
compare the diagnostic performance of QN
and QN2 for neonatal and infant faecal
specimens.
Patients and methods
Study population
This prospective, single-centre study was
conducted in the Department of
Paediatrics, Fukuyama Medical Centre,
Hiroshima, Japan between May 24, 2010
and March 29, 2012. Faecal samples were
collected monthly from all infants (with the
exception of those admitted to the NICU)
monthly, from birth to 12 months of age.
Specimens were numbered for later identifi-
cation, frozen and transferred to Denka
Seiken Kagamida Factory (Niigata,
Japan) for norovirus detection by immuno-
chromatography and real-time reverse
transcription polymerase chain reaction
(RT–PCR).
The study was approved by the
Institutional Ethics Committee, Fukuyama
Medical Centre, Hiroshima, Japan, in
accordance with the Declaration
of Helsinki. The parents of each infant
provided written informed consent prior to
participation in the study.
Immunochromatography
Faecal specimens were tested for the
presence of norovirus using QuickNavi-
Norovirus and QuickNavi-Norovirus 2,
according to the manufacturer’s instruc-
tions. The diagnostic performance of each
test was determined.
RT–PCR
All faecal specimens underwent real-time
RT–PCR for norovirus detection, as
described.9
Results
The study included faecal specimens from 81
healthy, full-term neonates (39 male/42
female; mean gestational age 39.3 1.4
weeks [range 37.1–41.9 weeks]; mean birth
weight 3017 311 g [range 2480–3994 g]).
A total of 362 faecal specimens were exam-
ined, 19 of which were excluded (three
obtained by enema [resulting in a high
probability of a false-positive result6]; 16
failed the QN test [due to absence of control
lines]). The final analysis included 343 spe-
cimens. Real-time RT–PCR identified nor-
ovirus GII cDNA in three specimens from
three separate asymptomatic infants. QN
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and QN2 tests were positive for all three
specimens.
The overall sensitivity, specificity, posi-
tive predictive value (PPV), negative pre-
dictive value (NPV) and accuracy of QN and
QN2 are shown in Table 1. The specificity,
PPV, NPV and accuracy of QN2 were
superior to QN in infants aged 0–12
months. When stratified according to age,
the specificity of QN was 33% (23/70) in the
neonatal period (infants aged <1 month),
rising to 93% (43/46) at 4 months of age
(Figure 1). The specificity of QN2 was 94%
(66/70) in the neonatal period and 100%
each month, for infants between 1 and
12 months of age (Figure 1).
Discussion
The present study is the first to evaluate
QuickNavi-Norovirus and QuickNavi-
Norovirus 2 in faecal specimens from neo-
nates and infants, and found that QN2
offers superior specificity to QN, particu-
larly during the neonatal period (aged <1
month). Others have reported false-positive
results using alternative norovirus rapid
detection tests in samples of neonatal
faeces. It was shown that 25/37 NICU
patients tested positive for norovirus using
an enzyme-linked immunosorbent assay
with 73% sensitivity and 100% specificity,
and 13 of these positive cases were negative
when tested via RT–PCR.10 In another
report, 22/43 NICU patients were norovirus
positive using an enzyme immunoassay
(EIA) with 77% sensitivity and 86% speci-
ficity, but 11 of the positive samples were
negative via RT–PCR.11 Similar findings
were reported in a NICU where five patients
who were positive for norovirus (using an
immunochromatographic test with 74%
sensitivity and 100% specificity) were all
shown to be negative for norovirus when
tested using RT–PCR.12 These data under-
score the need for confirmation of infection
by molecular assays, in conjunction with
rapid detection tests, when diagnosing nor-
ovirus infection in the neonatal period.
Rapid-detection tests for viruses other
than norovirus have also been shown to
generate high numbers of false positives in
neonatal samples. These include a pseudo-
outbreak of respiratory syncytial virus in a
NICU that was determined to be due to
cross reactivity between a lung surfactant
drug and the EIA used.13 False positives
have also been reported for adenovirus14
and rotavirus.15 The specificity of the tests
used in these studies is thought to be lower in
neonates than in adults and children.16-18
Particular care should be taken when using
these kits in the NICU setting. In addition,
variations in specificity should be considered
when new rapid detection tests are
developed.
Table 1. Diagnostic performance of QuickNavi-Norovirus and QuickNavi-Norovirus 2 (both Denka
Seiken Co., Ltd., Niigata, Japan) for detection of norovirus in faeces specimens from healthy, full-term infants
aged between 0 and 12 months (total 343 specimens from 81 infants). Real-time reverse transcription
polymerase chain reaction was used as gold standard for norovirus detection.
Parameter QuickNavi-Norovirus QuickNavi-Norovirus2
Sensitivity – (3/3) – (3/3)
Specificity 80 (275/343) 99 (339/343)
Positive predictive value 4 (3/71) 43 (3/7)
Negative predictive value 100 (275/275) 100 (339/339)
Accuracy 80 (278/346) 99 (342/346)
Data presented as % (n specimens).
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The present study has several limitations.
It was not possible to evaluate the sensitivity
of QN and QN2, because only three faecal
specimens were confirmed positive by real-
time RT–PCR. It is difficult to collect
norovirus-positive faeces from neonates
because of the low prevalence of the infec-
tion. The sensitivity of these tests for neo-
natal and infant faeces must be re-evaluated
in future. In addition, it was not possible to
determine the cause of the false positives in
the neonatal specimens. It is likely that
unknown substances unique to neonatal
and early infant faeces cross-react and
cause false-positive results with QN specif-
ically. The use of enemas or suppositories,
and specialized diets that include thickening
agents, may cause false-positives.6 Such
samples, however, were excluded from the
present study. The specificity of QN2 was
determined using rectal swab samples, the
use of which is known to reduce specificity in
QN.8 QN2 offers sufficient specificity with
rectal swab samples, but no substances
present in both rectal swabs and neonatal
faecal specimens have been shown to cause
cross reactions.
In conclusion, QN2 appears to offer
improved performance and be more useful
than QN for the diagnosis of norovirus
infection in the neonatal and infant period.
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Figure 1. Specificity of QuickNavi-Norovirus (QN) and QuickNavi-Norovirus 2 (QN2; both Denka
Seiken Co., Ltd., Niigata, Japan) for detection of norovirus in faecal specimens taken monthly from healthy,
full-term infants aged between 0 and 12 months, stratified by age (total 343 specimens from 81 infants).
Real-time reverse transcription polymerase chain reaction was used as the gold standard for norovirus
detection.
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